Frankfurt - Delayed Quote • EUR Lobe Sciences Ltd. (6YX0.F) Follow Compare 0.0105 +0.0015 +(16.67%) At close: December 27 at 3:46:35 PM GMT+1 Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 6YX0.F 1D 5D 0.00% 1M 75.00% 3M 162.50% 6M 75.00% YTD 0.00% 1Y 75.00% 5Y -98.40% All -98.40% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: 6YX0.F View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Lobe Sciences and Alera Pharma Announce Notice of Allowance for Second U.S. Patent for Conjugated Psilocin™ Lobe Sciences, Ltd. Announces the Appointment of Enclave Capital and Peak Asset Management to Fund Clinical Trials of Conjugated Psilocin™ Lobe Sciences and Alera Pharma Announce Issuance of U.S. Patent for Conjugated Psilocin™ Lobe Sciences Announces Creation of Wholly Owned Subsidiary, Alera Pharma, Inc. Lobe Sciences Announces Appointment of a New Board of Directors and Executive Management Team Lobe Sciences Announces Update Wesley Ramjeet to Join Lobe Sciences’ Board of Directors, Bringing Decades of Strategic Financial Expertise Lobe Sciences Announces Frederick D. Sancilio Ph.D. to Join Board of Directors Former Merck Director and Vanderbilt Vice-Chancellor, Dr. Harry Jacobson, to Join Lobe Sciences Board of Directors Lobe Sciences Ltd. and Clearway Global Announce Change of Control and Focus on Creating Value for Shareholders